Neurobiology of depression in relation to pharmacological-biochemical properties of antidepressants

Reference

• Åsberg M., Thoren P., TrÄskman L., Bertilsson L., Ringberger V. ‘Serotonin depression’ – a biochemical subgroup within the affective disorders. Science 1976; 191: 478–4801. Åsberg M., Thoren P., TrÄskman L., Bertilsson L., Ringberger V. ‘Serotonin depression’ – a biochemical subgroup within the affective disorders. Science 1976; 191: 478–480
   PubMed Web of Science ®Google Scholar
• Ashcroft G. W., Eccleston D., Murray L. G., Glen A. J., Crawford T. B. B., Pullar J. A., Shields P. J., Walter D. S., Blackburn J. M., Chonnechan J., Lonergan M. Modified amine hypothesis for the aetiology of affective illness. Lancet 1972; 2: 573–5772. Ashcroft G. W., Eccleston D., Murray L. G., Glen A. J., Crawford T. B. B., Pullar J. A., Shields P. J., Walter D. S., Blackburn J. M., Chonnechan J., Lonergan M. Modified amine hypothesis for the aetiology of affective illness. Lancet 1972; 2: 573–577
   PubMed Web of Science ®Google Scholar
• Banerjee S. P., Kung L. S., Riggi S. J., Chanda S. K. Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 1977; 268: 455–4563. Banerjee S. P., Kung L. S., Riggi S. J., Chanda S. K. Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 1977; 268: 455–456
   PubMed Web of Science ®Google Scholar
• Blackard W. G., Heidingsfelder S. A. Adrenergic receptor control mechanism for growth hormone secretion. J. Clin. Invest. 1978; 47: 1407–14144. Blackard W. G., Heidingsfelder S. A. Adrenergic receptor control mechanism for growth hormone secretion. J. Clin. Invest. 1978; 47: 1407–1414
   Google Scholar
• Baumann P. A., Maitre L. Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserin. Arch. Pharmacol. 1977; 300: 31–375. Baumann P. A., Maitre L. Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserin. Arch. Pharmacol. 1977; 300: 31–37
   Google Scholar
• Carroll B. J. The hypothalamic-pituitary-adrenal axis in depression. Depressive Illness: Some Research Studies, B. Davies, B. J. Carroll, R. M. Mowbray. Thomas, Springfield 19726. Carroll B. J. The hypothalamic-pituitary-adrenal axis in depression. Depressive Illness: Some Research Studies, B. Davies, B. J. Carroll, R. M. Mowbray. Thomas, Springfield 1972
   Google Scholar
• Carroll B. J. Neuroendocrine processes for the diagnosis of depression. Depressive Disorders (Symposia Medica Hoechst). Schattauer-Verlag, Stuttgart, New York 19777. Carroll B. J. Neuroendocrine processes for the diagnosis of depression. Depressive Disorders (Symposia Medica Hoechst). Schattauer-Verlag, Stuttgart, New York 1977
   Google Scholar
• Carroll B. J., Mendels J. Neuroendocrine regulation in affective disorders. Hormones, Behavior and Psychopathology. Raven Press, New York 19768. Carroll B. J., Mendels J. Neuroendocrine regulation in affective disorders. Hormones, Behavior and Psychopathology. Raven Press, New York 1976
   Google Scholar
• Casper R. C., Davis J. M., Pandey G. N., Garver D. L., Dekirmenjian H. Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology 1977; 2: 105–1149. Casper R. C., Davis J. M., Pandey G. N., Garver D. L., Dekirmenjian H. Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology 1977; 2: 105–114
   PubMed Web of Science ®Google Scholar
• Checkley S. A. Corticosteroid and growth hormone responses to methylamphetamine in depressive illness. Psychol. Med. 1979; 9: 107–11510. Checkley S. A. Corticosteroid and growth hormone responses to methylamphetamine in depressive illness. Psychol. Med. 1979; 9: 107–115
   PubMed Web of Science ®Google Scholar
• Checkley S. A., Crammer J. L. Hormone response to methylamphetamine in depression: a new approach to the noradrenaline depletion hypothesis. Br. J. Psychiatry 1977; 131: 582–58611. Checkley S. A., Crammer J. L. Hormone response to methylamphetamine in depression: a new approach to the noradrenaline depletion hypothesis. Br. J. Psychiatry 1977; 131: 582–586
   PubMed Web of Science ®Google Scholar
• Crews F. T., Smith C. B. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 1978; 202: 322–32412. Crews F. T., Smith C. B. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 1978; 202: 322–324
   PubMed Web of Science ®Google Scholar
• Czernik A. Veränderungen hypothalamisch-hypophysär gesteuerter Hormone bei Depressionen und durch Psychopharmaka. Südwestdeutsche Psychiater-Tagung. Baden-Baden 1978; 197813. Czernik A. Veränderungen hypothalamisch-hypophysär gesteuerter Hormone bei Depressionen und durch Psychopharmaka. Südwestdeutsche Psychiater-Tagung. Baden-Baden 1978; 1978
   Google Scholar
• Eden S., Modigh K. Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res. 1977; 129: 379–38414. Eden S., Modigh K. Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res. 1977; 129: 379–384
   PubMed Web of Science ®Google Scholar
• Endo M. Plasma growth hormone levels during insulin hypoglycemia in atypical psychosis. Folia Endocrinol. Jpn. 1970; 45: 129515. Endo M. Plasma growth hormone levels during insulin hypoglycemia in atypical psychosis. Folia Endocrinol. Jpn. 1970; 45: 1295
   Google Scholar
• Frazer A., Mendels J. Do tricyclic antidepressants enhance adrenergic transmission?. Am. J. Psychiatry 1977; 134: 1040–104216. Frazer A., Mendels J. Do tricyclic antidepressants enhance adrenergic transmission?. Am. J. Psychiatry 1977; 134: 1040–1042
   PubMed Web of Science ®Google Scholar
• Fuxe K., Ögren S.-O., Aganati L., Gustafsson J. K., Jonsson G. On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity. Neurosci. Letters 1977; 6: 339–34417. Fuxe K., Ögren S.-O., Aganati L., Gustafsson J. K., Jonsson G. On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity. Neurosci. Letters 1977; 6: 339–344
   PubMed Web of Science ®Google Scholar
• Gibbons J. L. Cortisol secretion rate in depressive illness. Arch. Gen. Psychiatry 1964; 10: 572–57518. Gibbons J. L. Cortisol secretion rate in depressive illness. Arch. Gen. Psychiatry 1964; 10: 572–575
   PubMed Web of Science ®Google Scholar
• Green A. R., Grahame-Smith D. G. Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 1976; 260: 487–49119. Green A. R., Grahame-Smith D. G. Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine. Nature 1976; 260: 487–491
   PubMed Web of Science ®Google Scholar
• Green A. R., Kelly P. H. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-dopa. Br. J. Pharmacol. 1975; 57: 141–14720. Green A. R., Kelly P. H. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-dopa. Br. J. Pharmacol. 1975; 57: 141–147
   Web of Science ®Google Scholar
• Jungkunz G., Kuss H. J. Amitriptyline and its demethylation rate. Lancet 1978; 2: 1263–126421. Jungkunz G., Kuss H. J. Amitriptyline and its demethylation rate. Lancet 1978; 2: 1263–1264
   PubMed Web of Science ®Google Scholar
• Klein D. F. Endogenomorphic depression. Arch. Gen. Psychiatry 1974; 31: 447–45422. Klein D. F. Endogenomorphic depression. Arch. Gen. Psychiatry 1974; 31: 447–454
   PubMed Web of Science ®Google Scholar
• Laakmann G., Benkert O. Neuroendokrinologie und Psychopharmaka. Arzneim. Forsch. 1978; 28: 1277–128023. Laakmann G., Benkert O. Neuroendokrinologie und Psychopharmaka. Arzneim. Forsch. 1978; 28: 1277–1280
   PubMed Web of Science ®Google Scholar
• Langer G. Neuroendokrinologie der Depression und Schizophrenic. Arzneim. Forsch. 1978; 28: 1280–128124. Langer G. Neuroendokrinologie der Depression und Schizophrenic. Arzneim. Forsch. 1978; 28: 1280–1281
   PubMedGoogle Scholar
• Langer G., Heinze G., Reim B., Matussek N. Reduced growth hormone response to amphetamine in endogenous depressive patients. Arch. Gen. Psychiatry 1976; 33: 1471–147525. Langer G., Heinze G., Reim B., Matussek N. Reduced growth hormone response to amphetamine in endogenous depressive patients. Arch. Gen. Psychiatry 1976; 33: 1471–1475
   PubMed Web of Science ®Google Scholar
• Maj J., Gancarczyk A., Rantow A. Doxepin as a blocker of central serotonin receptors. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 318–32426. Maj J., Gancarczyk A., Rantow A. Doxepin as a blocker of central serotonin receptors. Pharmakopsychiatr. Neuropsychopharmakol. 1977; 10: 318–324
   PubMedGoogle Scholar
• Maj J., Lewandowska A., Rantow A. Central antiserotonin action of amitriptyline. Pharmakopsychiatr. Neuropsychopharmacol. 1979; 12: 181–18527. Maj J., Lewandowska A., Rantow A. Central antiserotonin action of amitriptyline. Pharmakopsychiatr. Neuropsychopharmacol. 1979; 12: 181–185
   Google Scholar
• Matussek N. Psychopathologie der Zyklothymie und Schizophrenic. Psychiatrie der Gegenwart, J.-E. Meyer, E. Strömgren. Springer-Verlag, Heidelberg 197928. Matussek N. Psychopathologie der Zyklothymie und Schizophrenic. Psychiatrie der Gegenwart, J.-E. Meyer, E. Strömgren. Springer-Verlag, Heidelberg 1979
   Google Scholar
• Matussek N., Ackenheil M., Hippius H., Müller F., SchrÖder H.-Th., Schultes H., Wasilewski B. Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatt. Res. 1979, In Press29. Matussek N., Ackenheil M., Hippius H., Müller F., SchrÖder H.-Th., Schultes H., Wasilewski B. Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatt. Res. 1979, In Press
   Google Scholar
• Matussek N., Ackenheil M., Hippius H., SchrÖder H.-Th., Schultes H., Wasilewski B. Effect of clonidine on HGH release in psychiatric patients and controls. Paper read at VI. World Congress of Psychiatry, Hawaii 1977; 197730. Matussek N., Ackenheil M., Hippius H., SchrÖder H.-Th., Schultes H., Wasilewski B. Effect of clonidine on HGH release in psychiatric patients and controls. Paper read at VI. World Congress of Psychiatry, Hawaii 1977; 1977
   Google Scholar
• Modigh K. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine pretreated mice by repeated ECT. J. Neural Transm. 1975; 36: 19–3231. Modigh K. Electroconvulsive shock and postsynaptic catecholamine effects: increased psychomotor stimulant action of apomorphine and clonidine pretreated mice by repeated ECT. J. Neural Transm. 1975; 36: 19–32
   PubMed Web of Science ®Google Scholar
• Mueller P. S., Henninger G. R., McDonald R. K. Insulin tolerance test in depression. Arch. Gen. Psychiatry 1969; 21: 587–59432. Mueller P. S., Henninger G. R., McDonald R. K. Insulin tolerance test in depression. Arch. Gen. Psychiatry 1969; 21: 587–594
   PubMed Web of Science ®Google Scholar
• Muscettola G., Goodwin F. K., Potter W. Z., Claeys M. M., Markey S. P. Imipramine and desimipramine in plasma and spinal fluid. Relationship to clinical response and serotonin metabolism. Arch. Gen. Psychiatry 1978; 35: 621–62533. Muscettola G., Goodwin F. K., Potter W. Z., Claeys M. M., Markey S. P. Imipramine and desimipramine in plasma and spinal fluid. Relationship to clinical response and serotonin metabolism. Arch. Gen. Psychiatry 1978; 35: 621–625
   PubMed Web of Science ®Google Scholar
• Perez-Reyes M. Differences in the capacity of the sympathetic and endocrine systems of depressed patients to react to a physiological stress. Recent Advances in the Psychobiology of the Depressive Illness. Government Printing Office, Washington, DC 197234. Perez-Reyes M. Differences in the capacity of the sympathetic and endocrine systems of depressed patients to react to a physiological stress. Recent Advances in the Psychobiology of the Depressive Illness. Government Printing Office, Washington, DC 1972
   Google Scholar
• Rosenblatt J. E., Pert C. B., Tallman J. F., Pert A., Bunney W. E., Jr. The effect of imipramine and lithium on α- and β-receptor binding in rat brain. Brain Res. 1979; 160: 186–19135. Rosenblatt J. E., Pert C. B., Tallman J. F., Pert A., Bunney W. E., Jr. The effect of imipramine and lithium on α- and β-receptor binding in rat brain. Brain Res. 1979; 160: 186–191
   PubMed Web of Science ®Google Scholar
• Sachar E. J., Finkelstein J., Hellmann L. Growth hormone responses in depressive illness. I. Response to insulin tolerance test. Arch. Gen. Psychiatry 1971; 25: 263–26936. Sachar E. J., Finkelstein J., Hellmann L. Growth hormone responses in depressive illness. I. Response to insulin tolerance test. Arch. Gen. Psychiatry 1971; 25: 263–269
   Web of Science ®Google Scholar
• Sachar E. J., Roffwarg H. P., Gruen P. H., Altmann N., Sassin J. Neuroendocrine studies on depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1976; 9: 11–1737. Sachar E. J., Roffwarg H. P., Gruen P. H., Altmann N., Sassin J. Neuroendocrine studies on depressive illness. Pharmakopsychiatr. Neuropsychopharmakol. 1976; 9: 11–17
   PubMedGoogle Scholar
• Schlesser M. A., Winokur G., Sherman B. M. Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity. Lancet 1979; 1: 739–74138. Schlesser M. A., Winokur G., Sherman B. M. Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity. Lancet 1979; 1: 739–741
   PubMed Web of Science ®Google Scholar
• Sulser F., Vetulani J., Mobley P. L. Mode of action of antidepressant drugs. Biochem. Pharmacol. 1978; 27: 257–26139. Sulser F., Vetulani J., Mobley P. L. Mode of action of antidepressant drugs. Biochem. Pharmacol. 1978; 27: 257–261
   PubMed Web of Science ®Google Scholar
• TrÄskman L., Åsberg M., Bertilsson L., Cronholm B., MellstrÖm B., Neckers L. M., SjÖqvist F., Thoren P., Tybring G. Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Differential biochemical and clinical effects of the two compounds. Clin. Pharmacol. Ther. 1979, In Press40. TrÄskman L., Åsberg M., Bertilsson L., Cronholm B., MellstrÖm B., Neckers L. M., SjÖqvist F., Thoren P., Tybring G. Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Differential biochemical and clinical effects of the two compounds. Clin. Pharmacol. Ther. 1979, In Press
   PubMedGoogle Scholar
• van Praag H. M. New evidence of serotonin deficient depression. Depressive Disorders (Symposia Medica Hoechst). Schattauer-Verlag, Stuttgart, New York 197741. van Praag H. M. New evidence of serotonin deficient depression. Depressive Disorders (Symposia Medica Hoechst). Schattauer-Verlag, Stuttgart, New York 1977
   Google Scholar
• van Praag H. M. Central serotonin. Its relation to depression and depression prophylaxis. Biological Psychiatry Today, J. Obiols, C. Ballus, E. Gonzales, J. Pujol. Elsevier North-Holland Biochemical Press, Amsterdam 197942. van Praag H. M. Central serotonin. Its relation to depression and depression prophylaxis. Biological Psychiatry Today, J. Obiols, C. Ballus, E. Gonzales, J. Pujol. Elsevier North-Holland Biochemical Press, Amsterdam 1979
   Google Scholar